JP2023021276A5 - - Google Patents

Download PDF

Info

Publication number
JP2023021276A5
JP2023021276A5 JP2022198540A JP2022198540A JP2023021276A5 JP 2023021276 A5 JP2023021276 A5 JP 2023021276A5 JP 2022198540 A JP2022198540 A JP 2022198540A JP 2022198540 A JP2022198540 A JP 2022198540A JP 2023021276 A5 JP2023021276 A5 JP 2023021276A5
Authority
JP
Japan
Prior art keywords
pyridyl
alkyl
group
pyridin
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022198540A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023021276A (ja
Filing date
Publication date
Priority claimed from PCT/EP2018/072788 external-priority patent/WO2019038387A1/en
Application filed filed Critical
Publication of JP2023021276A publication Critical patent/JP2023021276A/ja
Publication of JP2023021276A5 publication Critical patent/JP2023021276A5/ja
Pending legal-status Critical Current

Links

JP2022198540A 2017-08-23 2022-12-13 ピリジルピリドン化合物 Pending JP2023021276A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17187544.6 2017-08-23
EP17187544 2017-08-23
PCT/EP2018/072788 WO2019038387A1 (en) 2017-08-23 2018-08-23 PYRIDYLPYRIDONE COMPOUNDS
JP2020510096A JP7199737B2 (ja) 2017-08-23 2018-08-23 ピリジルピリドン化合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020510096A Division JP7199737B2 (ja) 2017-08-23 2018-08-23 ピリジルピリドン化合物

Publications (2)

Publication Number Publication Date
JP2023021276A JP2023021276A (ja) 2023-02-10
JP2023021276A5 true JP2023021276A5 (cg-RX-API-DMAC7.html) 2023-08-25

Family

ID=59686881

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020510096A Active JP7199737B2 (ja) 2017-08-23 2018-08-23 ピリジルピリドン化合物
JP2022198540A Pending JP2023021276A (ja) 2017-08-23 2022-12-13 ピリジルピリドン化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020510096A Active JP7199737B2 (ja) 2017-08-23 2018-08-23 ピリジルピリドン化合物

Country Status (20)

Country Link
US (2) US11219618B2 (cg-RX-API-DMAC7.html)
EP (2) EP4056556A1 (cg-RX-API-DMAC7.html)
JP (2) JP7199737B2 (cg-RX-API-DMAC7.html)
KR (1) KR102730718B1 (cg-RX-API-DMAC7.html)
CN (3) CN111094244B (cg-RX-API-DMAC7.html)
AU (2) AU2018320416B2 (cg-RX-API-DMAC7.html)
CY (1) CY1125138T1 (cg-RX-API-DMAC7.html)
DK (1) DK3672941T3 (cg-RX-API-DMAC7.html)
ES (1) ES2910839T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20220571T1 (cg-RX-API-DMAC7.html)
HU (1) HUE058977T2 (cg-RX-API-DMAC7.html)
IL (3) IL302356A (cg-RX-API-DMAC7.html)
LT (1) LT3672941T (cg-RX-API-DMAC7.html)
PL (1) PL3672941T3 (cg-RX-API-DMAC7.html)
PT (1) PT3672941T (cg-RX-API-DMAC7.html)
RS (1) RS63161B1 (cg-RX-API-DMAC7.html)
SI (1) SI3672941T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202200183T1 (cg-RX-API-DMAC7.html)
TW (2) TWI787335B (cg-RX-API-DMAC7.html)
WO (1) WO2019038387A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020012651A2 (pt) 2017-12-22 2020-12-01 Ravenna Pharmaceuticals, Inc. compostos derivados de aril-bipiridina amina como inibidores da fosfatidilinositol fosfato quinase, composição farmacêutica compreendendo os mesmos e usos terapêuticos dos ditos compostos
JP2023550638A (ja) 2020-11-25 2023-12-04 デシフェラ・ファーマシューティカルズ,エルエルシー ウイルス感染症の処置に使用するための、vsp34阻害剤としてのモルホリノ誘導体
CN117083064A (zh) 2020-11-25 2023-11-17 德西费拉制药有限责任公司 作为vps34抑制剂用于治疗病毒感染的吡啶基吡啶酮衍生物
CA3228766A1 (en) * 2021-08-13 2023-02-16 Yasmin YU Combination therapy of vps34 inhibitors and sting agonist for use in the treatment of cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04011470A (es) * 2002-05-21 2005-02-14 Amgen Inc Compuestos heterociclicos sustituidos y metodos de uso.
TW200908984A (en) * 2007-08-07 2009-03-01 Piramal Life Sciences Ltd Pyridyl derivatives, their preparation and use
EA201390917A1 (ru) * 2010-12-21 2013-12-30 Новартис Аг Дигетероарильные соединения в качестве ингибиторов vps34
PT2655375E (pt) 2010-12-23 2015-03-02 Sanofi Sa Derivados de pirimidinona, sua preparação e sua utilização farmacêutica
GB201120317D0 (en) 2011-11-24 2012-01-04 Queen Mary & Westfield College Screening method
PE20150666A1 (es) * 2012-03-01 2015-05-06 Array Biopharma Inc Inhibidores de serina/treonina cinasa
HK1208681A1 (en) * 2012-06-12 2016-03-11 Abbvie Inc. Pyridinone and pyridazinone derivatives
FR2992314B1 (fr) 2012-06-22 2015-10-16 Sanofi Sa Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique
WO2015108881A1 (en) 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
TN2016000270A1 (en) * 2014-01-14 2017-10-06 Millennium Pharm Inc Heteroaryls and uses thereof.
MA39823A (fr) 2014-04-03 2018-01-09 Janssen Pharmaceutica Nv Dérivés de pyridine macrocyclique
MA39822A (fr) 2014-04-03 2018-02-06 Janssen Pharmaceutica Nv Dérivés de pyrimidine bicycle
WO2016001789A1 (en) * 2014-06-30 2016-01-07 Pfizer Inc. Pyrimidine derivatives as pi3k inhibitors for use in the treatment of cancer
PL3416945T3 (pl) * 2016-02-19 2020-12-28 Sprint Bioscience Ab Związki 6-arylo-4-(morfolin-4-ylo)-1h-pirydyn-2-onu przydatne w leczeniu nowotworu i cukrzycy
PT3416957T (pt) 2016-02-19 2020-09-25 Sprint Bioscience Ab Compostos 6-heterociclil-4-morfolin-4-ilpiridin-2-ona úteis para o tratamento do cancro e da diabetes

Similar Documents

Publication Publication Date Title
JP2010538076A5 (cg-RX-API-DMAC7.html)
JP2010501587A5 (cg-RX-API-DMAC7.html)
IL292488B2 (en) Pyridineamine-pyridone and pyrimidineamine-pyridone compounds
JP2019533694A5 (cg-RX-API-DMAC7.html)
JP2013506637A5 (cg-RX-API-DMAC7.html)
JP2022547617A5 (cg-RX-API-DMAC7.html)
JP2021504443A5 (cg-RX-API-DMAC7.html)
RU2003105805A (ru) Производные 4-фенилпиридина в качестве антагонистов рецепторов нейрокинина-1
KR101574906B1 (ko) 치환된 벤즈아마이드 유도체
JP2005526723A5 (cg-RX-API-DMAC7.html)
JP2014511869A5 (cg-RX-API-DMAC7.html)
JP2013503901A5 (cg-RX-API-DMAC7.html)
JP2009534421A5 (cg-RX-API-DMAC7.html)
JP2022510925A5 (cg-RX-API-DMAC7.html)
JP2011500693A5 (cg-RX-API-DMAC7.html)
JP2008509955A5 (cg-RX-API-DMAC7.html)
JP2007523905A5 (cg-RX-API-DMAC7.html)
HRP20161177T1 (hr) Modulator glukagonskog receptora
RU2009116670A (ru) Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
JP2007246474A (ja) ベンゼン誘導体
JP2007519754A5 (cg-RX-API-DMAC7.html)
JP2011509261A5 (cg-RX-API-DMAC7.html)
JP2006500369A5 (cg-RX-API-DMAC7.html)
JP2007519695A5 (cg-RX-API-DMAC7.html)
KR20120110123A (ko) 치환된 벤즈아마이드 유도체